Given that GATA2 has been reported as an oncogene [28], GATA2 expression was increased in ZFP90 knockout HCT116 cells (Fig. S5c), and ZFP90 knockout blocked colorectal carcinogenesis, we chose BMP4 as the biological candidate target of ZFP90 for validation. This evidence concerns the gene GATA2 and medical procedure.